Navigation Links
New MedPredict Report Highlights Recent Advances in Management of Malignant Hematology

SCOTTSDALE, Ariz., Jan. 15 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.  These reports are based on primary interviews conducted with hematologists from North America immediately following the American Society of Hematology (ASH) annual meeting.

This report, entitled "Thought Leader Insight & Analysis – Malignant Hematology," includes analysis of new research in Multiple Myeloma, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, Lymphoma, and Chronic Myelogenous Leukemia.  

"This report reflects on and analyzes the most important data presented at ASH, and clarifies the ways these data will change clinical practice," according to Jeff Berk, MedPredict president. "A key focus of the report is Multiple Myeloma (MM), which is being transformed into a chronic, but still life threatening disease.  The most exciting advances presented at ASH included both identifying the most effective combinations for induction therapy, and in establishing a role and practice standard for maintenance therapy in MM."

According to one MM Thought Leader interviewed for this report:  "I think the message was very positive in regards that maintenance matters, choice of induction strategy matters with less toxicity being important, and staying on treatment of some form or another is very critical."

The expert panel also discusses novel compounds in development for various hematologic malignancies, and the hurdles they will need to overcome to become viable options in this market.  

Companies and partnerships mentioned in this report includes: Allos, Ambit, Amgen, Arno Therapeutics, Antisoma, Biogen Idec/Elan, Biotest/ImmunoGen, Bristol-Myers Squibb, Bristol-Myers Squibb/Facet, Celgene, Celgene/Gloucester, Cephalon, ChemGenex, Cyclacel, Eisai, Genmab, Genzyme, Genzyme/Anormed, Genzyme/Bayer HealthCare Pharmaceuticals, Geron/Merck, GlaxoSmithKline, GlaxoSmithKline/Genmab, ImmunoGen, Immunomedics/Nycomed, Incyte, Keryx, Merck, Milteni Biotec, Novartis, Novartis/Vernalis, OXiGENE, PDL Biopharma, Proteolix/Onyx, Rigel, Seattle Genetics, Syndax, and Takeda/Millennium.

This report can be purchased by contacting MedPredict (  

About MedPredict

MedPredict maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories.  Based on primary interviews with these thought leaders, MedPredict publishes periodic reports to keep clients up-to-date on emerging trends and competitive activity.  The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.

SOURCE MedPredict



SOURCE MedPredict
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Landscape for Lung Cancer Therapies is Focus of New Post-ASCO MedPredict Report
2. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
3. New Report by BioTrends Research Group To Highlight The Launch Of ACTEMRA (tocilizumab)
4. Does the MS Market Need Another Interferon? Neurologists Provide Insight in the Wave One Report of LaunchTrends: EXTAVIA
5. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
6. BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties
7. Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
8. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
9. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
10. Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
11. Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
Post Your Comments:
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
Breaking Medicine Technology:
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
Breaking Medicine News(10 mins):